5 Value Stocks To Watch In The Basic Materials Sector

What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace…

What are Value Stocks?

A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company’s future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

Below is a list of notable value stocks in the basic materials sector:

  1. Chemours (NYSE:CC) – P/E: 5.94
  2. Teck Resources (NYSE:TECK) – P/E: 6.66
  3. Boise Cascade (NYSE:BCC) – P/E: 3.11
  4. Ascent Industries (NASDAQ:ACNT) – P/E: 3.55
  5. Steel Dynamics (NASDAQ:STLD) – P/E: 4.88

Most recently, Chemours reported earnings per share at $1.24, whereas in Q2 earnings per share sat at $1.89. Most recently, the company reported a dividend yield of 3.46%, which has increased by 0.52% from last quarter’s yield of 2.94%.

Most recently, Teck Resources reported earnings per share at $1.33, whereas in Q2 earnings per share sat at $2.55. Its most recent dividend yield is at 1.5%, which has increased by 0.05% from 1.45% in the previous quarter.

Boise Cascade has reported Q3 earnings per share at $5.52, which has increased by 0.55% compared to Q2, which was 5.49. This quarter, Ascent Industries experienced a decrease in earnings per share, which was $1.06 in Q2 and is now $0.06. Steel Dynamics saw a decrease in earnings per share from 6.73 in Q2 to $5.46 now. Its most recent dividend yield is at 1.48%, which has decreased by 0.18% from 1.66% in the previous quarter.

The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.

Total
0
Shares
Related Posts
Read More

Dermata Therapeutics Entred Agreements For The Immediate Exercise Of Certain Warrants To Purchase Up To An Aggregate Of 516,336 Shares Of The Co’s Common Stock, Having Exercise Prices Of $9.7665 And $32.40 Per Share

Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases and conditions, today announced the

DRMA